未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Pembrolizumab in Patients of Chinese Descent with Microsatellite Instability-high/Mismatch Repair Deficient Advanced Solid Tumors: KEYNOTE-158 Final Analysis Wu, Xiaohua; Mao, Yimin; Xu, Nong; Bai, Yuxian; Wang, Dong; Chen, Xiaojun; Yin, Xianli; Deng, Yanhong; Yang, Jianwei; Zhang, Jieqing; Tang, Jie; Huang, Yi; Li, Jiayi; Luo, Suxia; Zheng, Hong; Zhao, Weidong; Xu, Miaomiao; Li, Nan; Mao, Yixiang; Gozman, Alexander; Xu, Jianming 分享 收藏
First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-306 一线Tislelizumab联合化疗治疗程序性死亡配体1表达 ≥ 1% 的食管鳞状细胞癌: 原理306的回顾性分析 Xu, Jianming; Kato, Ken; Hubner, Richard; Park, Sook Ryun; Kojima, Takashi; Ishihara, Ryu; Wyrwicz, Lucjan; Van Cutsem, Eric; Jimenez-Fonseca, Paula; Wu, Hongqian; Wang, Lei; Yan, Sebastian; Shi, Jingwen; Kadva, Alysha; Yoon, Harry H. 分享 收藏
分享 收藏
Expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) Tang, Haowen; Zhang, Wenwen; Cao, Junning; Cao, Yinbiao; Bi, Xinyu; Zhao, Haitao; Zhang, Ze; Liu, Zhe; Wan, Tao; Lang, Ren; Sun, Wenbing; Du, Shunda; Yang, Yongping; Lu, Yinying; Zeng, Daobing; Wu, Jushan; Duan, Binwei; Lin, Dongdong; Li, Fei; Meng, Qinghua; Zhou, Jun; Xing, Baocai; Tian, Xiaodong; Zhu, Jiye; Gao, Jie; Hao, Chunyi; Wang, Zhiqiang; Duan, Feng; Wang, Zhijun; Wang, Maoqiang; Liang, Bin; Chen, Yongwei; Xu, Yinzhe; Li, Kai; Li, Chengang; Hu, Minggen; Wang, Zhaohai; Cai, Shouwang; Ji, Wenbin; Xia, Nianxin; Zheng, Wenheng; Wang, Hongguang; Li, Gong; Zhu, Ziman; Huang, Zhiyong; Zhang, Wanguang; Tao, Kaishan; Liang, Jun; Zhang, Keming; Dai, Chaoliu; Li, Jiangtao; Qiu, Qiu; Guo, Yuan; Wu, Liqun; Ding, Weibao; Zhu, Zhenyu; Gu, Wanqing; Cao, Jingyu; Wang, Zusen; Tian, Lantian; Ding, Huiguo; Li, Guangming; Zeng, Yongyi; Wang, Kui; Yang, Ning; Jin, Haosheng; Chen, Yajin; Yang, Yinmo; Xiu, Dianrong; Yan, Maolin; Wang, Xiaodong; Han, Quanli; Jiao, Shunchang; Tan, Guang; Wang, Jizhou; Liu, Lianxin; Song, Jinghai; Liao, Jiajie; Zhao, Hong; Li, Peng; Song, Tianqiang; Wang, Zhanbo; Yuan, Jing; Hu, Bingyang; Yuan, Yufeng; Zhang, Meng; Sun, Shuyang; Zhang, Jialin; Wang, Wentao; Wen, Tianfu; Yang, Jiayin; Du, Xilin; Peng, Tao; Xia, Feng; Liu, Zuojin; Niu, Weibo; Liang, Ping; Xu, Jianming; Zhao, Xiao; Zhu, Min; Wang, Huaizhi; Kuang, Ming; Shen, Shunli; Cui, Xing; Zhou, Jinxue; Liu, Rong; Sun, Huichuan; Fan, Jia; Chen, Xiaoping; Zhou, Jian; Cai, Jianqiang; Lu, Shichun 分享 收藏
Comparison of Jinzhen oral liquid and ambroxol hydrochloride and clenbuterol hydrochloride oral solution in the treatment of acute bronchitis in children: A multicenter, non-inferiority, prospective, randomized controlled trial 金珍口服液与氨溴索氢氯盐和克仑特罗氢氯盐口服溶液在儿童急性支气管炎治疗中的比较：一项多中心、非劣效性、前瞻性、随机对照试验 Fan, QH; Wu, CM; Du, YW; Wang, BY; Xie, YM; Zhang, ZL; Su, WQ; Wang, ZZ; Xu, CC; Li, XK; Ding, Y; An, XJ; Chen, J; Xiao, YY; Yu, R; Li, N; Wang, J; Teng, YQ; Lv, HF; Yang, N; Wen, YL; Huang, XL; Pan, W; Liu, YF; Xi, XQ; Zhao, QY; Liu, CS; Xu, J; Zhang, HT; Zhuo, L; Rong, QQ; Xia, Y; Shen, Q; Li, S; Wang, JH; Wu, SX 分享 收藏
Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition) Yang, Yu; Sun, Juxian; Cai, Jianqiang; Chen, Minshan; Dai, Chaoliu; Wen, Tianfu; Xia, Jinglin; Ying, Mingang; Zhang, Zhiwei; Zhang, Xuewen; Fang, Chihua; Shen, Feng; An, Ping; Cai, Qingxian; Cao, Jingyu; Zeng, Zhen; Chen, Gang; Chen, Juan; Chen, Ping; Chen, Yongshun; Shan, Yunfeng; Dang, Shuangsuo; Guo, Wei-Xing; He, Jiefeng; Hu, Heping; Huang, Bin; Jia, Weidong; Jiang, Kexiang; Jin, Yan; Jin, Yongdong; Jin, Yun; Li, Gong; Liang, Yun; Liu, Enyu; Liu, Hao; Peng, Wei; Peng, Zhenwei; Peng, Zhiyi; Qian, Yeben; Ren, Wanhua; Shi, Jie; Song, Yusheng; Tao, Min; Tie, Jun; Wan, Xueying; Wang, Bin; Wang, Jin; Wang, Kai; Wang, Kang; Wang, Xin; Wei, Wenjing; Wu, Fei-Xiang; Xiang, Bangde; Xie, Lin; Xu, Jianming; Yan, Mao-Lin; Ye, Yufu; Yue, Jinbo; Zhang, Xiaoxun; Zhang, Yu; Zhang, Aibin; Zhao, Haitao; Zhao, Weifeng; Zheng, Xin; Zhou, Hongkun; Zhou, Huabang; Zhou, Jun; Zhou, Xinmin; Cheng, Shu-Qun; Li, Qiu 分享 收藏
MK-2870-015: A phase III study of trophoblast antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) vs treatment of physician's choice (TPC) for previously treated metastatic gastroesophageal adenocarcinoma (GEA) MK-2870-015：一项针对滋养层抗原2（TROP2）导向的抗体偶联药物（ADC）sacituzumab tirumotecan（sac-TMT）与研究者选择的治疗方案（TPC）用于既往治疗过的转移性胃食管腺癌（GEA）的III期研究 Wainberg, Z. A.; Van Cutsem, E.; Shitara, K.; Janjigian, Y. Y.; Oh, D-Y.; Xu, J.; Wu, S.; Bhaumik, S.; Bhagia, P.; Tabernero, J. 分享 收藏
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT in advanced or metastatic esophageal squamous cell carcinoma (ESCC): PD-L1 biomarker analysis from RATIONALE-306 Raymond, E.; Xu, J.; Kato, K.; Hubner, R.; Shu, Y.; Park, S. R.; Kojima, T.; Wyrwicz, L. S.; Tougeron, D.; Geboes, K.; Van Cutsem, E.; Pazo Cid, R. A.; Zaanan, A.; McLachlan, S-A.; Wu, H.; Shi, J.; Li, L.; Yan, S.; Yoon, H. 分享 收藏
分享 收藏
Oxidized low-density lipoprotein changes the inflammatory status and metabolomics profiles in human and mouse macrophages and microglia Sun, Yaru; Liang, Jia-Jian; Xu, Jianming; Zhou, Kewen; Fu, Changzhen; Chen, Shao-Lang; Yang, Rucui; Ng, Tsz Kin; Liu, Qingping; Zhang, Mingzhi 分享 收藏
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial Zhang, Panpan; Shi, Si; Xu, Jianming; Chen, Zhendong; Song, Lijie; Zhang, Xing; Cheng, Ying; Zhang, Yanqiao; Ye, Feng; Li, Zhiping; Yin, Fei; Ji, Dongmei; Gao, Heli; Li, Yi; Chen, Wei; Yang, Minjie; Weng, Desheng; Wu, Chunjiao; Ma, Yue; Sheng, Wang; Zhao, Yaqin; Yin, Xiaolei; Shen, Weina; Su, Weiguo; Shi, Michael; Fan, Songhua; Tan, Panfeng; Xu, Qian; Lu, Min; Shen, Lin 分享 收藏
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study Yan, X. Q.; Yey, M. J.; Zou, Q.; Chen, P.; He, Z. S.; Wu, B.; He, D. L.; He, C. H.; Xue, X. Y.; Ji, Z. G.; Chen, H.; Zhang, S.; Liu, Y. P.; Zhang, X. D.; Fu, C.; Xu, D. F.; Qiu, M. X.; Lv, J. J.; Huang, J.; Ren, X. B.; Cheng, Y.; Qin, W. J.; Zhang, X.; Zhou, F. J.; Ma, L. L.; Guo, J. M.; Ding, D. G.; Wei, S. Z.; He, Y.; Guo, H. Q.; Shi, B. K.; Liu, L.; Liu, F.; Hu, Z. Q.; Jin, X. M.; Yang, L.; Zhu, S. X.; Liu, J. H.; Huang, Y. H.; Xu, T.; Liu, B.; Sun, T.; Wang, Z. J.; Jiang, H. W.; Yu, D. X.; Zhou, A. P.; Jiang, J.; Luan, G. D.; Jin, C. L.; Xu, J.; Hu, J. X.; Huang, Y. R.; Guo, J.; Zhai, W.; Sheng, X. N. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
Nature Communications.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏